ATE382050T1 - Buprenorphinesterderivate, verfahren zu ihrer herstellung, und langwirksame analgetische arzneimittel - Google Patents

Buprenorphinesterderivate, verfahren zu ihrer herstellung, und langwirksame analgetische arzneimittel

Info

Publication number
ATE382050T1
ATE382050T1 AT02258083T AT02258083T ATE382050T1 AT E382050 T1 ATE382050 T1 AT E382050T1 AT 02258083 T AT02258083 T AT 02258083T AT 02258083 T AT02258083 T AT 02258083T AT E382050 T1 ATE382050 T1 AT E382050T1
Authority
AT
Austria
Prior art keywords
ester derivatives
buprenorphine
long
production
acting analgesic
Prior art date
Application number
AT02258083T
Other languages
English (en)
Inventor
Jhi-Joung Wang
Original Assignee
Chi Mei Foundation Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chi Mei Foundation Medical Ct filed Critical Chi Mei Foundation Medical Ct
Application granted granted Critical
Publication of ATE382050T1 publication Critical patent/ATE382050T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02258083T 2002-11-25 2002-11-25 Buprenorphinesterderivate, verfahren zu ihrer herstellung, und langwirksame analgetische arzneimittel ATE382050T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02258083A EP1422230B1 (de) 2002-11-25 2002-11-25 Buprenorphinesterderivate, Verfahren zu ihrer Herstellung, und langwirksame analgetische Arzneimittel

Publications (1)

Publication Number Publication Date
ATE382050T1 true ATE382050T1 (de) 2008-01-15

Family

ID=32187266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02258083T ATE382050T1 (de) 2002-11-25 2002-11-25 Buprenorphinesterderivate, verfahren zu ihrer herstellung, und langwirksame analgetische arzneimittel

Country Status (3)

Country Link
EP (1) EP1422230B1 (de)
AT (1) ATE382050T1 (de)
DE (1) DE60224288T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
EP1554290B1 (de) * 2002-10-25 2009-09-30 Euro-Celtique S.A. Analoga und prodrugs von buprenorphin
US7220842B2 (en) 2004-04-05 2007-05-22 Dade Behring Inc. Immunoassays for buprenorphine and norbuprenorphine
GB0606124D0 (en) 2006-03-28 2006-05-03 Reckitt Benckiser Healthcare Buprenorphine derivatives and uses thereof
EP2562177A3 (de) * 2006-09-22 2013-04-10 AllTranz Inc. Transdermal freisetzbare Buprenorphin-Prodrugs und missbrauchsichere Zusammensetzungen daraus
FR2975912B1 (fr) * 2011-05-30 2013-06-14 Flamel Tech Sa Composition a liberation controlee de buprenorphine
PL3137081T3 (pl) 2014-04-28 2018-06-29 Orphomed, Inc. Dimer buprenorfiny i jego zastosowanie w leczeniu chorób układu pokarmowego
GB201419091D0 (en) 2014-10-27 2014-12-10 Camurus Ab Formulations
SG11201901294QA (en) * 2016-09-13 2019-03-28 Alar Pharmaceuticals Inc Sustained-release buprenorphine formulations background of invention
AR117426A1 (es) 2018-05-11 2021-08-04 Alar Pharmaceuticals Inc Formulaciones inyectables de acción prolongada y formas cristalinas de derivados de buprenorfina
WO2020012245A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Thienothiophene-naltrexone prodrugs for long-acting injectable compositions
US10799496B2 (en) 2018-07-13 2020-10-13 Alkermes Pharma Ireland Limited Naphthylenyl compounds for long-acting injectable compositions and related methods
US10975099B2 (en) 2018-11-05 2021-04-13 Alkermes Pharma Ireland Limited Thiophene compounds for long-acting injectable compositions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3701693B2 (ja) * 1993-12-28 2005-10-05 日本製薬株式会社 鎮痛薬含有注射用徐放性脂肪乳剤
GB9423542D0 (en) * 1994-11-22 1995-01-11 Marples Brian A Pharmaceutical compounds
WO1996028451A1 (en) * 1995-03-14 1996-09-19 Euroceltique S.A. Morphine-3-esters

Also Published As

Publication number Publication date
DE60224288T2 (de) 2009-04-16
DE60224288D1 (de) 2008-02-07
EP1422230A1 (de) 2004-05-26
EP1422230B1 (de) 2007-12-26

Similar Documents

Publication Publication Date Title
ATE382050T1 (de) Buprenorphinesterderivate, verfahren zu ihrer herstellung, und langwirksame analgetische arzneimittel
ATE386017T1 (de) Carbonsäureamid substituierte phenylharnstoffderivate, verfahren zu ihrer herstellung als arzneimittel
GB0220581D0 (en) Organic Compound
DK0810868T3 (da) Anvendelse af piperidin som et biotilgængelighedsforøgende middel
ATE524443T1 (de) Bicyclische inhibitoren von mek und verfahren zu deren herstellung
DE60215851D1 (de) N-adamantylmethyl-derivate und zwischenprodukte als pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
GEP20074133B (en) New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
DK1086124T3 (da) Nye cyclosporiner
WO2006005741A3 (en) Piperdine derivatives as renin inhibitors
DE50307267D1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
HUP0102851A2 (hu) Parazitaellenes artemizinin-származékok (endoperoxidok), eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
BRPI0413393A (pt) fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina
DE50304569D1 (de) Xanthencarbonsäureester des tropenols und scopins als m3-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE602004022646D1 (de) Kristalline form iii von wasserfreiem moxifloxacin-hydrochlorid und ein verfahren zu seiner herstellung
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE231850T1 (de) Isochroman verbindungen und verfahren zu deren produktion
ATE284901T1 (de) Veresterte polysaccharidprodukte, beta-lacton ringgeöffnete ketendimer-produkte enthaltende zusammensetzungen und verfahren zur deren herstellung
WO2004043920A8 (en) Polymorphs of bicifadine hydrochloride
TNSN04024A1 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
CA2412047A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
AU2003237052A8 (en) Process for preparing (r)-aryloxypropionic acid ester derivatives
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
DE69710909D1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
WO2005037780A3 (de) Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties